[ad_1]
Pharmaceutical companies have recalled hundreds of antihypertensive drugs such as valsartan, losartan and irbesartan, alone or in combination with other drugs.
The detected ingredient has been identified as N-methylnitrosobutyric acid (NMBA), a known animal and potentially carcinogenic to humans.
Torrent Pharmaceuticals Limited expands the recall of Losartan Potbadium Tablets USP and Losartan Potbadium / Hydrochlorothiazide Tablets, USP, to consumers, due to the detection of traces of an unexpected impurity found in a pharmaceutical active ingredient manufactured by Hetero Labs Limited.
According to the FDA, losartan is used to treat hypertension, hypertensive patients with left ventricular hypertrophy and to treat nephropathy in type 2 diabetics. Tablets containing hydrochlorothiazide are used to treat rheumatoid arthritis. Hypertension and hypertension in hypertensive patients.
The FDA advises patients taking these medications to continue taking them until they can find an alternative. The company said the recall was only for products with more FDA authorized NMBA than allowed. A complete list of all the recalled medications is also available.
Any general inquiries regarding the return of this product should be directed to Qualanex at 1-888-280-2040 (live calls received from 8:00 am to 9:00 pm Eastern Time).
The recall involves losartan potbadium tablets and losartan / hydrochlorothiazide potbadium tablets.
[ad_2]
Source link
